December 2021 "Early-stage studies of COVID-19 treatments from the likes of Vir Biotechnology Inc. and was first identified in South Africa in early November, and an existing treatment has already shown positive shots against the variant, the monoclonal antibody sotrovimab from Vir and partner GlaxoSmithKline PLC posted Sotrovimab is the first monoclonal antibody showing preclinical efficacy against all COVID-19 variants

November 2021 Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID

Research over the past years has provided a substantial body of evidence demonstrating that platelets also participate in host innate immunity. In light of the current COVID-19 pandemic, the topic of immunothrombosis has become more relevant than ever, as a majority of COVID-19 patients display thrombi in the lung capillaries and other vascular

GPCR News < GPCRs in Oncology and Immunology Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). This observational study aims to evaluate the efficacy of IA in patients with post-COVID-19 ME/CFS. Due to the urgency of finding therapies for post-COVID-Syndrome (PCS), we report here the interim results , SF-36 , autoantibodies , immunoadsorption , long COVID , physical function , post-COVID syndrome Source

< GPCR News < GPCRs in Oncology and Immunology Severity of neurological long-COVID symptoms correlates autonomic nervous system receptors Published date September 7, 2023 Abstract "Background: The Long-COVID syndrome constitutes a plethora of persisting symptoms with neurological disorders being the most disabling The pathogenesis of Long-COVID is currently under heavy scrutiny and existing data on the role of auto-immune moderate SARS-CoV-2 infection up to 12 months prior to enrollment with (n = 72) or without (n = 58) Long-COVID

Immunology G protein-coupled receptors related to autoimmunity in postural orthostatic tachycardia syndrome Published date June 20, 2024 Abstract "Postural orthostatic tachycardia syndrome (POTS) is characterized To date, POTS is recognized as one of the sequelae of coronavirus disease 2019 (COVID-19) and its frequency Multiple autoantibody types occur in COVID-related, autonomic disorders, suggesting the presence of autoimmune , and provide a new perspective for understanding POTS-related autoimmunity."